Jeena Sikho Lifecare Ltd.

₹659.9

-24.3 (-3.6%)

JSLL Share Price

Pharmaceuticals & Biotechnology

As on January 27, 2026

Sector

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 8,230 Cr

P/E Ratio242.79

Dividend Yield0.03 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	682.32	Bearish
10-DMA	697.38	Bearish
20-DMA	689.24	Bearish
50-DMA	702.19	Bearish
100-DMA	735.98	Bearish
200-DMA	616.01	Bullish

Historical Performance

1 Year

78.5%

3 Years

1937.4%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2023	Mar-2022
Net Sales	2,048	1,466
Total Expenditure	1,589	1,285
Other Income	26	15
Operating Profit	484	196
Interest	9	12
Depreciation	32	33
Profit Before Tax	443	151
Consolidated Net Profit	338	112
Adjusted EPS	3	1

Compounded Sales Growth

10 Years:6.9

5 Years:6.9

3 Years:6.9

TTM:6.9

Compounded Profit Growth

10 Years:24.6

5 Years:24.6

3 Years:24.6

TTM:24.6

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:173.1

TTM:83.6

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:N/A

last year:2.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2023	Mar-2022
Share Capital	138	101
Total Reserves	1,120	264
Long-Term Borrowings	---	---
Total Non-Current Liabilities	2	12
Other Current Liabilities	139	119
Short Term Borrowings	---	64
Total Liabilities	1,506	615
Capital Work in Progress	11	50
Long Term Loans & Advances	122	64
Currents Investments	45	---
Short Term Loans and Advances	131	32
Total Current Assets	775	215
Total Assets	1,506	615
Adjusted Book Value	10	4

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 242.79, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 173.6%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹484 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹2048 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1835043.5

No. of Shares: 2781 (Approx)

Performance:83.5%

P/L: ₹835043.5

NIFTY Performance: 9.7%

1 day Top Gainers